Clearmind Medicine Inc
CMND0.774USD
-0.037-4.51%
終値 11/04, 16:00（ET）15分遅れの株価
4.16M時価総額
損失額直近12ヶ月PER
詳細情報 Clearmind Medicine Inc 企業名
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.
Clearmind Medicine Incの企業情報
企業コードCMND
会社名Clearmind Medicine Inc
上場日Aug 10, 2021
最高経営責任者「CEO」Dr. Adi Zuloff-Shani
従業員数- -
証券種類Ordinary Share
決算期末Aug 10
本社所在地101-1220 West 6Th Avenue
都市VANCOUVER
証券取引所NASDAQ Capital Market Consolidated
国Canada
郵便番号V6H 1A5
電話番号16042601566
ウェブサイトhttps://www.clearmindmedicine.com/
企業コードCMND
上場日Aug 10, 2021
最高経営責任者「CEO」Dr. Adi Zuloff-Shani
Clearmind Medicine Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
39.83K
-27.76%
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
24.75K
+161.59%
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
12.50K
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Ms. Hila Kiron-Revach
Ms. Hila Kiron-Revach
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
39.83K
-27.76%
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
24.75K
+161.59%
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
12.50K
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Fri, Oct 31
更新時刻: Fri, Oct 31
株主統計
種類
株主統計
株主統計
比率
Gotham Asset Management, LLC
6.40%
AdvisorShares Investments, LLC
3.83%
Shani (Adi Zuloff)
1.01%
Weiss (Amitay)
0.74%
Rootenberg (Alan)
0.46%
他の
87.56%
株主統計
株主統計
比率
Gotham Asset Management, LLC
6.40%
AdvisorShares Investments, LLC
3.83%
Shani (Adi Zuloff)
1.01%
Weiss (Amitay)
0.74%
Rootenberg (Alan)
0.46%
他の
87.56%
種類
株主統計
比率
Investment Advisor/Hedge Fund
6.40%
Investment Advisor
3.89%
Individual Investor
2.67%
Venture Capital
0.21%
Research Firm
0.07%
他の
86.75%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
20
569.42K
10.58%
-450.78K
2025Q2
27
768.21K
14.28%
-538.45K
2025Q1
28
780.42K
14.56%
-476.27K
2024Q4
29
785.22K
17.91%
-399.68K
2024Q3
27
937.11K
23.14%
+595.17K
2024Q2
25
525.49K
14.81%
+343.69K
2024Q1
26
524.19K
16.46%
+392.16K
2023Q4
23
150.91K
8.83%
+103.68K
2023Q3
22
47.49K
21.65%
+21.51K
2023Q2
20
27.10K
18.95%
+488.00
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Gotham Asset Management, LLC
344.52K
6.4%
+1.09K
+0.32%
Jun 30, 2025
AdvisorShares Investments, LLC
205.93K
3.83%
-15.00K
-6.79%
Jun 30, 2025
Shani (Adi Zuloff)
54.23K
1.01%
+52.57K
+3153.45%
Oct 31, 2024
Weiss (Amitay)
39.83K
0.74%
-15.31K
-27.76%
Dec 01, 2024
Rootenberg (Alan)
24.75K
0.46%
+15.29K
+161.59%
May 13, 2025
Shachar (Yehonatan Samuel)
12.50K
0.23%
--
--
Dec 01, 2024
Itzhaik (Asaf)
12.50K
0.23%
--
--
Dec 01, 2024
XTX Markets LLC
11.52K
0.21%
+11.52K
--
Jun 30, 2025
J.P. Morgan Securities LLC
3.54K
0.07%
+3.54K
--
Jun 30, 2025
Morgan Stanley Smith Barney LLC
2.56K
0.05%
--
--
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Sun, Nov 2
更新時刻: Sun, Nov 2
銘柄名
比率
AdvisorShares Psychedelics ETF
1.67%
Fidelity Nasdaq Composite Index ETF
0%
AdvisorShares Psychedelics ETF
比率1.67%
Fidelity Nasdaq Composite Index ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
日付
種類
比率
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
